Anhui Wanbang Pharmaceutical Technology Co.,Ltd. (SHE:301520)
China · Delayed Price · Currency is CNY 58.05
-7.47 (-11.40%)
At close: Nov 13, 2026
SHE:301520 Market Cap
SHE:301520 has a market cap or net worth of 5.39 billion as of November 13, 2026. It is the 10,538th most valuable company in the world and the 2,450th biggest in China. Its market cap has increased by 85.97% in one year.
Market Cap
5.39B
Enterprise Value
4.49B
Revenue
248.98M
Global Rank
Country Rank
#2,450 China
PE Ratio
1,377.09
ChartMarket Cap Chart
Since September 25, 2023, SHE:301520's market cap has increased from 4.93B to 5.39B, an increase of 9.16%. That is a compound annual growth rate of 2.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 5.39B | 104.56% |
| Dec 31, 2025 | 2.63B | 2.57% |
| Dec 31, 2024 | 2.57B | -30.38% |
| Dec 29, 2023 | 3.69B | -25.27% |
| Sep 25, 2023 | 4.93B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hunan Er-Kang Pharmaceutical | 6.04B |
| Guizhou Bailing Group Pharmaceutical | 6.01B |
| Cisen Pharmaceutical | 5.93B |
| Beijing Sun-Novo Pharmaceutical Research | 5.91B |
| Bide Pharmatech | 5.84B |
| Jinghua Pharmaceutical Group | 5.83B |
| HPGC Renmintongtai Pharmaceutical | 5.80B |
| Suzhou Highfine Biotech | 5.74B |